market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention FreightCar America, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.9 for that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Coherus BioSciences
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention FreightCar America, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.9 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 3.5 for the same window. We currently track 1 Supply Chain story that mention Coherus BioSciences, all published on March 8, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Supply Chain stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Coherus BioSciences. Shared-story counts are live from our verified record — not editorial picks.
FreightCar America's upcoming Q4 2025 earnings report will serve as a critical barometer for the health of North American rail logistics and equipment demand. As the company navigates a shifting industrial landscape, its performance reflects broader trends in freight volume and infrastructure investment.